This statistic displays the projected top 20 products for neurology diseases based on revenue in the United States during 2016 . In that year , Abilify , an Otsuka product , is expected to generate approximately 322 million U.S. dollars in revenues , a decrease of some 1.7 billion dollars compared to 2014 , caused by patent loss .
